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SUMMARY
Histoplasmosis is a systemic mycosis caused by Histoplasma capsulatum, which may present itself as a serious infection in 
immunocompromised individuals. We present a case of 31-year-old female with newly diagnosed HIV infection and history of fever, 
general and respiratory symptoms and diffuse hyperchromic papules through the body. She was admitted, with rapid progression to 
septic shock, and the presence of neutrophils filled with yeast-like organisms was detected on peripheral blood smear hematoscopia 
on the third day of hospitalization. The following is a brief review on the clinical picture and management of histoplasmosis.
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INTRODUCTION
Histoplasmosis is a systemic mycosis caused by a dimorphic fungus 
called Histoplasma capsulatum. It is classically considered an endemic 
mycosis, although the fungus has an opportunistic behavior in patients 
with depressed cellular immunity.
Humans acquire the infection through the inhalation of conidia 
present in nature (bats found in caves and chicken stool). The clinical 
picture can vary from asymptomatic to severe disseminated infections. 
The diagnosis is based on the detection of the fungus in body fluids 
(sputum, blood, cerebrospinal fluid) or tissues (histopathology), the 
culture of biological and serological assays.
Treatment of the acute severe, chronic respiratory or localized forms 
can be done with oral azoles (itraconazole) and, in the disseminated form, 
amphotericin B is the drug of choice for initiating therapy (preferably 
lipid formulations).
Histoplasmosis is one of the most important systemic mycosis in the 
Americas, with widespread distribution in all regions of Brazil5,18. This 
paper aims to report a case of septic shock in a patient with disseminated 
histoplasmosis associated with acquired immunodeficiency syndrome 
(AIDS).
CASE REPORT
The patient was a 31-year-old female, born in Várzea da Palma-MG, 
admitted, by the emergency room, with productive cough with sputum, 
unmeasured fever, sore throat, fatigue, weight loss and hyporexia for 
a month. The patient reported the appearance of diffuse non-pruritic 
hyperpigmented papules throughout the body, and ulceration in the 
lower lip for 60 days.
On physical examination she presented a compromised general 
state of health, prostrated, a mild conjunctival pallor, hydrated, afebrile, 
mild edema of lower limbs and diffuse hypertrophic papules with sizes 
ranging from 0.5 to 1.0 cm through the body. The vital signs showed blood 
pressure (BP) of 90x60 mmHg, heart rate of 130 bpm, and respiratory 
rate of 30 rpm. Oroscopy showed mild enanthem of the oropharynx and 
purpuric patch on the lower lip.
On the first day of hospitalization, the patient remained asthenic 
and developed a productive cough, mucoid sputum and hemoptysis. 
Furthermore, a HIV serology was ordered, which retrieved a positive 
result. In the second day, she had diarrhea and fecal incontinence. 
Doses of clindamycin, ceftriaxone and sulfamethoxazole-trimethoprim 
were started. On the third day, the patient showed a decreased level of 
consciousness, hypoxemia and cardiopulmonary arrest (CPA) that was 
reversed with resuscitation maneuvers.
The patient also showed a Glasgow Coma Score (GCS) of 3, 
hemodynamic instability, inaudible BP and diminished vesicular murmurs 
bilaterally. An intubation was performed and mechanical ventilation, 
norepinephrine and dopamine were initiated. Patient status remained 
severe, with septic shock, unresponsive to resuscitation measures and 
high doses of amines. Blood gas analysis revealed severe metabolic 
acidosis and hypoxemia. Chest radiography showed diffuse bilateral 
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infiltrates, representative of the Acute Respiratory Distress Syndrome 
(ARDS). Peripheral blood smear was performed which revealed the 
presence of neutrophils filled with yeast-like organisms suggestive 
of Histoplasma capsulatum (Fig. 1). Amphotericin deoxycholate, 
vancomycin, piperacillin and tazobactam were then begun. In the fourth 
day, the patient presented another CRA in asystole and died.
DISCUSSION
Histoplasmosis is acquired through inhalation of conidia in nature. 
Most inhaled conidia arrive intact in the alveoli and stimulate a host’s 
inflammatory response, consisting of mononuclear cells and macrophages, 
which are unable to destroy the microorganism. Histoplasma capsulatum 
multiplies inside the cells of the immune system and, through the lung, 
they enter into the perihilar and mediastinal lymph nodes and then into 
the systemic circulation, producing inflammatory foci in other organs 
such as the spleen and bone marrow.
After the second and third weeks of the onset of infection, it 
develops a cellular response of Th1 type, which will produce gamma-
interferon and other cytokines that activate macrophages, which have 
the capacity to lyse the intracellular yeast Histoplasma capsulatum. 
This type of immune response leads to healing of primary infection 
and in this state, people become very resistant to reinfection, but these 
are exceptional cases. Fungi can remain viable in scarred areas for 
several years.
Immunosuppression appears to be a major factor in triggering the 
reactivation of previous infection. Histoplasma capsulatum can be 
considered one of the most important opportunistic pathogens of the 
human body. Patients with lymphoma, heart, liver or renal transplant, 
patients using high doses of corticosteroids, and particularly AIDS 
patients may develop severe cases of disseminated histoplasmosis, 
resulting from the recrudescence of latent infections and, less frequently, 
new exposures to the microorganism in hyperendemic areas. As the 
patient of the current report was from a region where there are old houses 
and the tradition of breeding chickens, there was probably exposure to 
environments contaminated with the fungus, particularly chicken runs and 
roofs of abandoned houses. However, there are no studies of the actual 
occurrence of Histoplasmosis in this region that could characterize the 
area as hyperendemic.
The clinical form presented by individuals who become infected, 
depends upon the immune response, although, the inhaled inoculum 
size also has its importance. Patients with disseminated forms of the 
mycosis, like the patient of the current report, show a Th2-type immune 
response that produces IL4, IL5 and IL10, which inhibit the protective 
Th1 response. In this case, the granulomas are absents or poorly formed, 
there is a great proliferation of macrophages in tissues, the histoplasmin 
skin test is negative, the antibody titers are high and the course of disease 
is acute and severe5.
Primary infection with Histoplasma capsulatum, regardless of the 
presence of the symptoms may progress to the fungus spreading to the 
whole body, particularly to macrophage rich organs. Normally, as the 
specific anti-Histoplasma immunity develops, infection is controlled 
in the secondary metastatic foci and diagnosis may only be performed 
incidentally by biopsy showing the presence of yeast forms of the 
agent2,3,7,17.
 
Rarely, a small number of individuals with apparently normal 
immune systems or those with some form of immunosuppression may 
develop symptomatic disseminated histoplasmosis. Several conditions 
that evolve with cellular immune depression might influence the spread 
of the agent and, before the AIDS epidemic; patients with hematologic 
malignancies (leukemias, lymphomas), renal transplant patients, collagen 
diseases and sarcoidosis patients, corticosteroids users and those with 
primary cellular immunodeficiencies were the ones who most commonly 
developed systemic forms of the mycosis.
In AIDS patients, histoplasmosis is a severe, often fatal disease that 
occurs when the level of CD4 is below 200 cells/mm3. In the patient 
of the current report, the level of CD4 and other relevant laboratorial 
data could not be investigated, since the disease progressed rapidly 
after the diagnosis. Accordingly, patients with AIDS often show a rapid 
progression of the disease with high fever, severe anorexia, malaise, 
nausea or vomiting, dyspnea, weight loss, generalized lymphadenopathy 
and hepatosplenomegaly. Disseminated skin lesions, as those of the case 
reported, are a common manifestation in these patients. Skin lesions 
can also be localized and involvement of the mucosa might occur. Bone 
marrow involvement is common and it is manifested by peripheral 
pancytopenia. Interestingly, pulmonary involvement in systemic 
histoplasmosis is rare, although, in severe cases of the disease, a miliary 
or interstitial pattern can be observed on chest radiographs. 
Other laboratory abnormalities such as elevated liver enzymes 
(especially alkaline phosphatase and gamma-glutamyl transpeptidase), 
lactate dehydrogenase and ferritin, aside of hypoalbuminemia are 
commonly observed in these patients. Skin lesions, such as those reported 
in the patient, are very common in cases of histoplasmosis diagnosed 
in Latin America and may occur in up to half of diagnosed cases. They 
are polymorphic and are presented in the form of papules, nodules, 
ulcerations and located or ulcerated molluscoid lesions. Ulcerated 
mucosal lesions may occur in up to one third of cases2-4,7,15,17.
Fig. 1 - A neutrophil filled with yeast-like organisms suggestive of Histoplasma capsulatum.
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The patient of the current case report evolved with septic shock and 
lethal outcome. Indeed, with some patients the severe disseminated forms 
can exhibit a sepsis-like syndrome with hypotension, shock, disseminated 
intravascular coagulation and respiratory distress syndrome in adults with 
high mortality rates. Death is the spontaneous evolution of these clinical 
forms in most cases14,16.
The diagnosis of histoplasmosis is based on finding the fungus 
on secretions and/or tissues and on particular serological reactions. In 
progressive disseminated histoplasmosis, the fungus can be seen on 
microscopic examination of smears of the peripheral blood, as occurred 
in this case report, as well as in bone marrow, skin or mucous lesion 
exudates, sputum and cerebrospinal fluid (CSF). The cultures of any of 
these materials may be positive. Blood cultures often isolate the causative 
agent, particularly in patients with AIDS. The histopathology is another 
way to make a diagnosis of histoplasmosis. Biopsies of skin or mucosa, 
lung, bone marrow, liver, lymph nodes and intestines show the presence of 
epithelioid granulomas, with a sarcoid aspect, where the microorganisms 
can be seen within phagocytic cells; special stains such as Gomori-Grocott 
and PAS are necessary for adequate visualization of the fungus11.
Several serological tests with different sensitivities and specificities 
are available for the diagnosis of histoplasmosis. Immunodiffusion 
and complement fixation, using histoplasmin as antigen show positive 
results in about 80% of patients, including those with self-limited acute 
infection. False-negatives may occur in immunocompromised patients 
with disseminated disease.
Complement fixation tests with titles of 1/32 or larger are suggestive 
of active infection. The immunodiffusion test is more specific, but 
less sensitive than the complement fixation. Immunoenzymatic 
techniques (ELISA) have also already standardized for the diagnosis of 
histoplasmosis and the previously accumulated clinical experience shows 
that these are more sensitive and specific than complement fixation11.
The antigen detection is the most useful method for the serological 
diagnosis of disseminated histoplasmosis in AIDS patients. Polysaccharide 
antigen of the fungus has been detected in the blood or in the urine in 
85% and 95% of infected individuals, respectively. The test can also 
be applied in the cerebrospinal fluid and in respiratory secretions. 
Radioimmunoassay was the technique used for the fungus detection 
and is now commercially available. Skin tests using the histoplasmin are 
not recommended for the diagnosis, because a positive result does not 
distinguish past from current infection. Even a negative result does not 
rule out active disease. These tests are ideal for epidemiological studies 
in endemic areas of the mycosis16. Finally, detection methods based on 
polymerase chain reaction (PCR) have also been developed recently, 
although they lack standardization8. In the current report, as the fungus 
was found to be present in the peripheral blood smear, none of these 
methods were necessary. Nevertheless, in other cases, they can aid in 
the early diagnosis and treatment of the disease10. 
In the primary therapy of disseminated histoplasmosis, particularly 
in patients with AIDS, amphotericin B is the drug of choice and must be 
administered in a total dose of 35 mg/kg (total dose for adults between 
2.0 and 2.5 g). About 75%-80% of patients show complete remission 
of clinical manifestations; but, when the drug is suspended, recurrences 
are common.
Long term maintenance therapy is required to maintain clinical 
remission in these patients; the amphotericin B at a dose of 1 mg/kg, twice 
weekly, may be an alternative, although the dose of itraconazole 200 mg 
PO once daily is also highly effective in this situation. Lipid formulations 
of amphotericin B at a dose of 3 to 5 mg/kg/day can also be employed and 
appear to be more effective than the deoxycholate formulation. After 1-2 
weeks of use, and improvement of the patient, the sequential treatment 
with itraconazole must be performed13,15,16.
Despite the well-established treatment protocols, histoplasmosis 
remains a serious condition in a patient with AIDS, with mortality rates 
of up to 50%4, which reinforces the need for new therapies and prevention 
strategies. Accordingly, new therapeutic targets, such as protein Hcp100 
of the H. capsulatum, have been investigated and may result in the 
emergence of new drugs6. Prevention strategies to reduce exposure 
include avoiding caving or participation in demolitions in places known 
to be contaminated by H. capsulatum. In addition, in locations with an 
incidence of histoplasmosis higher than 10 cases per 100 patients-years, 
itraconazole 200 mg daily may be used prophylactically to patients with 
CD4 counts less than 150/mcL13. Moreover, the large proportion of 
histoplasmosis patients who do not know to be infected with HIV or who 
are not making appropriate use of antiretroviral therapy of high efficiency 
reinforces the importance of screening programs of HIV infection and 
strategies for increasing the adherence4,5.
RESUMO
Choque séptico em paciente com histoplasmose disseminada 
associada à AIDS: relato de caso
A histoplasmose é micose sistêmica causada por Histoplasma 
capsulatum, a qual pode se apresentar de forma grave em indivíduos 
imunocomprometidos. Neste trabalho, apresenta-se o caso de paciente 
feminino, 31 anos, com diagnóstico recente de infecção por HIV e quadro 
de febre, sintomas gerais e respiratórios e pápulas hipercrômicas difusas 
pelo corpo. Foi internada, apresentando progressão rápida para choque 
séptico, sendo detectada a presença de leveduras inclusas em neutrófilos 
à hematoscopia no terceiro dia de internação. Apresenta-se uma revisão 
breve sobre a apresentação e o manejo clínico da histoplasmose.
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